Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
02/27/2003 | US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
02/27/2003 | CA2457436A1 Peptide arginals and methods for treating disseminated intravascular coagulation |
02/26/2003 | EP1285658A2 Treatments for female sexual dysfunction |
02/26/2003 | EP1285651A1 Melanin concentrating hormone antagonists |
02/26/2003 | EP1284962A2 Method for obtaining pure n-vinyl pyrrolidone |
02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
02/26/2003 | EP1204639A4 Synthesis of a novel paramagnetic amino acid derivative (epm-5) for labelling chemical and biological macromolecules |
02/26/2003 | EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use |
02/26/2003 | CN1398853A Production process of pyrrolidone carboxylic acid and its salt |
02/26/2003 | CN1102142C Novel N-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use |
02/25/2003 | US6525215 HIV protease inhibitors |
02/25/2003 | US6525087 Use of known agonists of the central cannabinoid receptor CB1 |
02/25/2003 | US6525085 Diaryl-enynes |
02/25/2003 | US6525079 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
02/25/2003 | US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases |
02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
02/25/2003 | US6525042 Sulfonyl derivatives |
02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
02/25/2003 | CA2053513C Bis- and tris(trifluoromethyl)arylpyrrole insecticidal and acaricidal agents |
02/25/2003 | CA2042243C N-acylated arylpyrroles useful as insecticidal, acaricidal, nematicidal and molluscicidal agents |
02/21/2003 | CA2398766A1 Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction |
02/20/2003 | WO2003014106A1 METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER |
02/20/2003 | WO2003014080A2 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
02/20/2003 | WO2003014069A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
02/20/2003 | WO2003013571A1 Peptidomimetics of biologically active metallopeptides |
02/20/2003 | WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
02/20/2003 | WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands |
02/20/2003 | WO2003013508A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
02/20/2003 | US20030036660 As chemical intermediate |
02/20/2003 | US20030036659 Method for the production of n-alkenyl amides |
02/20/2003 | US20030036654 Useful as mediators of protein-protein interactions |
02/20/2003 | US20030036618 Exposing polymer and photoacid generator with a light of 180 nm or less wavelength, and conducting baking and development. |
02/20/2003 | CA2462200A1 Peptidomimetics of biologically active metallopeptides |
02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
02/20/2003 | CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/20/2003 | CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
02/19/2003 | EP1284260A1 Tyrosine phosphatase inhibitors |
02/19/2003 | EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof |
02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
02/19/2003 | CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them |
02/18/2003 | US6521761 Primary intermediates for oxidative coloration of hair |
02/18/2003 | US6521760 Process for the preparation of zofenopril calcium salt |
02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
02/18/2003 | US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion |
02/18/2003 | US6521612 Antibiotic compounds |
02/18/2003 | US6521592 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
02/18/2003 | US6521431 Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments |
02/18/2003 | US6521097 Distilling mixture comprising an N-(C1-C18)-alkyl-2-pyrrolidone and hydrogen chloride in presence of water, condensing water as water-hydrogen chloride azeotrope at the top by cooling, returning, separation |
02/13/2003 | WO2003012900A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
02/13/2003 | WO2003011826A1 Crystalline forms vi and vii of atorvastatin calcium |
02/13/2003 | WO2003011825A1 Pyrrolidine derivatives and method of synthesizing these |
02/13/2003 | WO2003011824A1 Bicyclic modulators of androgen receptor function |
02/13/2003 | WO2003011450A1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof |
02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
02/13/2003 | US20030032625 Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors |
02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
02/12/2003 | EP1023294B1 Carbapenem derivatives and a preparation method thereof |
02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
02/12/2003 | CN1396819A Novel coupler for use in oxidative hair dyeing |
02/12/2003 | CN1101380C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
02/11/2003 | US6518437 Process and intermediate compounds for the preparation of pyrrolidines |
02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
02/11/2003 | US6518299 Substituted pyrrolidine compounds useful as neuraminidase inhibitors |
02/11/2003 | US6517992 N-sulfonyloxyimide compound and radiation-sensitive resin composition using the same |
02/11/2003 | US6517811 Compounds for cancer imaging and therapy |
02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
02/11/2003 | CA2092284C Conditioning shampoo composition and method of preparing and using the same |
02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
02/06/2003 | WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
02/06/2003 | WO2002096420A3 Method for treating nerve injury caused by surgery |
02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
02/06/2003 | US20030028048 Optically active materials |
02/06/2003 | US20030028035 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone |
02/06/2003 | US20030027852 Substituted pyrrolidine-2,3,4-trione 3-oxime deerivatives which are active as NMDA receptor antagonists |
02/06/2003 | US20030027850 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
02/06/2003 | US20030027830 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer |
02/06/2003 | US20030027822 Sodium channel modulators |
02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
02/05/2003 | EP1281746A2 Photo-alignment materials for liquid crystal alignment film |
02/05/2003 | EP1280847A1 Oligo/polysuccinimides, process for producing thereof and their use |
02/05/2003 | EP1280770A1 C 2? phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
02/05/2003 | EP1280769A1 Method for processing pyrollidone and n-vinyl pyrollidone residues |
02/05/2003 | EP1280765A2 Fluorous tagging compounds and their use |
02/05/2003 | EP1280527A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
02/05/2003 | CN1395507A Catalysts comprising N-substituted cyclic imides and processes for prepairing organic compounds with catalysts |